Provided by Tiger Trade Technology Pte. Ltd.

Hutchison China Meditech

15.36
+0.06000.39%
Volume:18.15K
Turnover:279.15K
Market Cap:2.68B
PE:5.91
High:15.52
Open:15.33
Low:15.30
Close:15.30
52wk High:19.50
52wk Low:12.98
Shares:174.43M
Float Shares:104.00M
Volume Ratio:0.61
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.60
EPS(LYR):2.60
ROE:45.25%
ROA:-1.62%
PB:2.16
PE(LYR):5.91

Loading ...

Company Profile

Company Name:
Hutchison China Meditech
Exchange:
NASDAQ
Establishment Date:
2000
Employees:
1796
Office Location:
Cheung Kong Center,48th floor,2 Queen's Road Central,Hong Kong,Hong Kong
Zip Code:
- -
Fax:
- -
Introduction:
HUTCHMED (China) Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through two segments. Oncology Immunology segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Among it, research and development (R&D) includes research and development activities covering drug discovery, development, manufacturing and regulatory functions, out-licensing of in-house developed drugs, as well as administrative activities to support research and development operations, marketed products comprises the invoiced sales, marketing, manufacture and distribution of drugs developed from research and development activities. Other Ventures segment is engaged in the other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and healthcare products.

Directors

Name
Position
CHENG Chig Fung, Johnny
Acting Chief Executive Officer and Chief Financial Officer and Executive Director
Dan ELDAR
Chairman and Non-executive Director
Weiguo SU
Chief Executive Officer and Chief Scientific Officer and Executive Director
Chaohong HU
Independent Non-executive Director
Edith SHIH
Company Secretary and Non-executive Director
Ling YANG
Non-executive Director
Renu BHATIA
Senior and Lead Independent Non-executive Director
TAN Shao Weng, Daniel
Independent Non-executive Director
WONG Tak Wai
Independent Non-executive Director

Shareholders

Name
Position
CHENG Chig Fung, Johnny
Acting Chief Executive Officer and Chief Financial Officer and Executive Director
Weiguo SU
Chief Executive Officer and Chief Scientific Officer and Executive Director
Lorenso CHIU
Deputy Chief Financial Officer
Charles George Rupert NIXON
Group General Counsel
Edith SHIH
Company Secretary and Non-executive Director